ANVISA: What Brazil Device Teams Need to Know

Read the video transcript

Entering Brazil with a medical device? ANVISA is central to the plan. The useful question is not simply whether you need approval, but which route fits your product.

ANVISA is Brazil’s health regulatory agency. For devices, it oversees product authorization, manufacturing requirements and safety once products are on the market.

Begin with your intended use and the device’s characteristics. Put the product, its technical description and its supporting evidence side by side before building a submission.

Under the general device framework, classes one and two use notification. Classes three and four require registration. Notification does not remove your responsibility to meet the applicable requirements.

Separate medical devices from in vitro diagnostics when selecting the rules. The main device framework is RDC seven fifty-one; in vitro diagnostics have their own regulation.

Your label and instructions also need attention. Review the Portuguese information and product identifiers against the dossier, rather than treating labeling as a last-minute design task.

For an overseas manufacturer, map the local applicant arrangement, the evidence for your route and the responsibilities after launch. Budgeting becomes more useful once those pieces are clear.

ANVISA requirements extend beyond getting a number on a certificate. Our glossary connects the agency’s role with Brazil’s classification, registration and post-market guidance.

Read the full glossary at Pure Global. One partner for medical device registration and regulatory support across more than thirty markets.